- Home
- SLQT vs EYPT Comparison
SLQT vs EYPT Comparison
Compare SLQT & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLQT
- EYPT
- Stock Information
- Founded
- SLQT 1999
- EYPT 1987
- Country
- SLQT United States
- EYPT United States
- Employees
- SLQT N/A
- EYPT N/A
- Industry
- SLQT Specialty Insurers
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- SLQT Finance
- EYPT Industrials
- Exchange
- SLQT Nasdaq
- EYPT Nasdaq
- Market Cap
- SLQT 386.9M
- EYPT 579.4M
- IPO Year
- SLQT 2020
- EYPT 2005
- Fundamental
- Price
- SLQT $2.44
- EYPT $10.36
- Analyst Decision
- SLQT Hold
- EYPT Strong Buy
- Analyst Count
- SLQT 2
- EYPT 8
- Target Price
- SLQT $3.38
- EYPT $24.75
- AVG Volume (30 Days)
- SLQT 968.0K
- EYPT 811.1K
- Earning Date
- SLQT 05-12-2025
- EYPT 08-06-2025
- Dividend Yield
- SLQT N/A
- EYPT N/A
- EPS Growth
- SLQT N/A
- EYPT N/A
- EPS
- SLQT N/A
- EYPT N/A
- Revenue
- SLQT $1,488,701,000.00
- EYPT $56,042,000.00
- Revenue This Year
- SLQT $17.72
- EYPT N/A
- Revenue Next Year
- SLQT $13.05
- EYPT N/A
- P/E Ratio
- SLQT N/A
- EYPT N/A
- Revenue Growth
- SLQT 20.41
- EYPT 12.04
- 52 Week Low
- SLQT $1.62
- EYPT $3.91
- 52 Week High
- SLQT $6.86
- EYPT $13.99
- Technical
- Relative Strength Index (RSI)
- SLQT 53.19
- EYPT 61.63
- Support Level
- SLQT $2.35
- EYPT $9.45
- Resistance Level
- SLQT $2.69
- EYPT $11.69
- Average True Range (ATR)
- SLQT 0.13
- EYPT 0.83
- MACD
- SLQT 0.03
- EYPT 0.03
- Stochastic Oscillator
- SLQT 52.83
- EYPT 64.53
About SLQT SelectQuote Inc.
SelectQuote Inc is a Direct-to-consumer (DTC) distribution platform which facilitates consumers to shop for health, life and auto & home insurance policies online. The company generates its revenues by selling insurance products on behalf of the insurance carrier partners in the form of a commission. It has four reportable segments namely Senior, Healthcare Services, Life, and Auto & Home. It functions through three lines namely, SelectQuote Senior, SelectQuote Life, and SelectQuote Auto & Home.
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.